|
- Amgen - A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics
- Amgen - Wikipedia
Amgen Inc is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California The company is ranked 18th on the list of largest biomedical companies by revenue
- Amgen weaves in UK biotech with up to $840M acquisition
Amgen is adding Dark Blue to its tapestry, embedding the U K biotech’s preclinical blood cancer program into its organization The California pharma has stitched together a deal worth up to
- Amgen Inc. (AMGN) Stock Price, News, Quote History - Yahoo Finance
Find the latest Amgen Inc (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing
- Products | Amgen
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options With a presence in approximately 100 countries, we are proud to have reached millions of people with our products
- Amgen buys protein-degrading startup Dark Blue for up to $840M
Amgen buys protein-degrading startup Dark Blue for up to $840M The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that could set it apart from current medications
- Advancing Oncology at the Speed of Life | Amgen Oncology
At Amgen we are committed to changing the course of cancer treatment for more than 40 years Learn about all of the different Amgen Oncology web propoerties and resources that Amgen has to offer
- About Us - Amgen, Inc
Since 2004, Amgen Ventures has invested in emerging companies to help discover promising medicines and technologies that will bring transformative medicines to patients
|
|
|